See analyst estimates and all valuation multiples for Pharma Diagnostics & Analytics
| Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| $11.1B | 27.5x | 85.0x | |
| $8.5B | 7.0x | 20.2x | |
| $1.0B | 4.3x | -7.4x | |
| $1.0B | 5.5x | -14.6x | |
| $964M | 21.2x | n/a | |
| $183M | 10.3x | -22.5x | |
| $169M | 6.4x | -5.7x | |
| $158M | 9.1x | 11.8x | |
| $35.5M | 15.1x | -9.1x | |
| $34.5M | 2.1x | 11.2x | |
| $19.2M | n/a | n/a | |
| $13.8M | n/a | n/a | |
| -$0.8M | n/a | 0.0x | |
| -$22.0M | -0.8x | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharma Diagnostics & Analytics